USGrantedDrug combination

Compositions and methods comprising a combination of serotonergic drugs

US-11974984-B2

Bibliographic data

Patent number
US-11974984-B2
Jurisdiction
US
Status
Granted
Type
Drug combination
Priority date
9 February 2017
Filing date
11 November 2020
Grant date
7 May 2024

Analysis

This is the case that best illustrates what a curated prior-art library can do. CaaMTech applied for broad claims over combinations of serotonergic drugs, psilocybin, LSD and MDMA, paired with cannabinoids, terpenes and SSRIs.

Porta Sophia filed a third-party submission in November 2021. The original eighteen claims were cancelled and narrowed to seven before the patent granted in 2024. It is a concrete example of prior art shaping the boundaries of a patent rather than blocking it outright, which is often the more realistic and more useful outcome.

Third-party submission

Challenged application
Compositions and methods comprising a combination of serotonergic drugs
Application number
US 17/095,430
Assignee / inventor
CaaMTech, Inc. / Andrew R. Chadeayne

Prosecution log

  1. Porta Sophia filed a third-party preissuance submission of prior art against the application.

  2. Granted as US-11974984-B2 with claims narrowed from the original 18 to 7.